Irrigated Ablation Catheter Market to Make Great Impact in Near Future by 2016 - 2024

Catheter ablation is a procedure which is used to remove the affected heart tissues that cause a heart rhythm problem. Ablation catheters are passed through the blood vessel in the neck, arm and threaded into the heart to remove the affected heart tissues that cause abnormal heart rhythm by using radiofrequency (RF) as the source of energy. Arrhythmias occur when electrical signals in the heart do not work properly. Medicines used in arrhythmias are to control abnormal heart rhythm, but catheter ablation devices remove the affected tissue.

Request for Report Sample: https://www.persistencemarketresearch.com/samples/12178

In February 2016, irrigated ablation catheter manufactured by Boston Scientific Corporation, received the approval from the U.S. Food and Drug Administration. Irrigated ablation catheter is used to diagnose and treat a condition called type I atrial flutter. Atrial flutter is the condition the cause heart to beat too fast leading to heart failure or stroke. Some of the common symptoms include palpitations, presyncope, mild dyspnea, and fatigue. Irrigation ablation catheter uses total tip cooling technology that is used to cool the catheter tip during the ablation procedure. In open irrigation catheter, radiofrequency energy is used to destroy the place in the tissue that causes atrial flutter.

Request for Report TOC: https://www.persistencemarketresearch.com/toc/12178

Technological advancements, advanced product pipeline and growing awareness of patient safety and monitoring are some of the key drivers that are fuelling the growth of irrigated ablation catheter market. However, high research and development expenses in product development and the low awareness about irrigated ablation catheter in the developing countries is anticipated to hamper the growth of irrigated ablation catheter market. According to National Center for Chronic Disease Prevention and Health Promotion, atrial fibrillation cost $6 billion each year in the United States. Medical expenses of people suffering from atrial fibrillation are about $8,705 higher per year compare to people who do not have atrial fibrillation.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.